2m 2m 2m 2m 2m 2m 2m
The Greater Cbs (GCAN)
OTC
$0.25-$0.08 (-24.68%)
Price as of Aug 18, 2026- $248,893.00Market Cap
- -44.38%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
The Greater Cbs (GCAN)
$0.25-$0.08 (-24.68%)
GCAN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.25 | ||
Change | -$0.08 (-24.68%) | ||
Open | $0.34 | ||
High | $0.34 | ||
Low | $0.23 | ||
Previous Close | $0.33 | ||
Volume | 29,970 | ||
30-Day Average Volume | 4,712 | ||
1-Week Change | -10.61% | ||
1-Month Change | -16.57% | ||
1-Year Change | -44.38% | ||
3-Year Change | -76.16% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 994,379 | ||
Total Assets | $111.00 | ||
Market Cap | $248,893.00 | ||
Enterprise Value | $271,282.00 | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$6,828.00 | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | -$12,128.00 | ||
EPS | $0.61 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | -21 | ||
P/E | 0 | ||
PEG | N/A | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 1500 | ||
Last Split Date | 10/17/2025 | ||
Earnings & Revenue